APA (7th ed.) Citation

TSUBOTA, A. (2004). Blood HCV dynamic phase by Amplicor HCV monitor v2.0 ( the high range method ) for the high-dense region measurement. The identification of virological refractoriness example in the phase I. The examination in the administration in PEG-IFN.ALPHA.-2b/IFN.ALPHA.-2b+ ribavirin combined use 48 weeks for chronic hepatitis C of high HCV quantity and HCV genotype 1b. Kanzo, 45(5), 280-281. https://doi.org/10.2957/kanzo.45.280

Chicago Style (17th ed.) Citation

TSUBOTA, AKITO. "Blood HCV Dynamic Phase by Amplicor HCV Monitor V2.0 ( the High Range Method ) for the High-dense Region Measurement. The Identification of Virological Refractoriness Example in the Phase I. The Examination in the Administration in PEG-IFN.ALPHA.-2b/IFN.ALPHA.-2b+ Ribavirin Combined Use 48 Weeks for Chronic Hepatitis C of High HCV Quantity and HCV Genotype 1b." Kanzo 45, no. 5 (2004): 280-281. https://doi.org/10.2957/kanzo.45.280.

MLA (9th ed.) Citation

TSUBOTA, AKITO. "Blood HCV Dynamic Phase by Amplicor HCV Monitor V2.0 ( the High Range Method ) for the High-dense Region Measurement. The Identification of Virological Refractoriness Example in the Phase I. The Examination in the Administration in PEG-IFN.ALPHA.-2b/IFN.ALPHA.-2b+ Ribavirin Combined Use 48 Weeks for Chronic Hepatitis C of High HCV Quantity and HCV Genotype 1b." Kanzo, vol. 45, no. 5, 2004, pp. 280-281, https://doi.org/10.2957/kanzo.45.280.